TDC
MRTX

Thompson Davis & Co’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Thompson Davis & Co’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q3 		$41K Sell
875
-375
-30% -$17.6K 0.09% 235
2018
Q2 		$62K Hold
1,250
– – 0.15% 157
2018
Q1 		$38K Sell
1,250
-250
-17% -$7.6K 0.1% 209
2017
Q4 		$27K Buy
1,500
+1,000
+200% +$18K 0.06% 276
2017
Q3 		$6K Buy
+500
New +$6K 0.01% 828